rucaparib,abiraterone,enzalutamide
astellas,pfizer,clovis oncology
['gu ', 'rucaparib', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'triton3']
watch alan h. bryce ( ) talk about the #triton3 phase 3 data on #rucaparib versus physician's choice for metastatic castration-resistant prostate cancer in our exclusive interview from #gu23: 
GU Oncology Now delivers the latest news in therapeutics, clinical trials, conference coverage, and important advancements in the genitourinary oncology field.